Ziyang Cao Selected Research

Ziyang Cao Research Topics

Disease

26	Neoplasms (Cancer) 11/2023 - 07/2014
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 05/2023 - 10/2021
2	Lung Neoplasms (Lung Cancer) 01/2021 - 09/2019
1	Leukemia 10/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2023
1	Non-alcoholic Fatty Liver Disease 11/2022
1	Neuroblastoma 01/2022
1	Melanoma (Melanoma, Malignant) 10/2021
1	Hyperthermia 05/2021
1	Residual Neoplasm 05/2021
1	Carcinogenesis 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 07/2020
1	Pain (Aches) 01/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Genomic Instability 01/2018
1	Hypoxia (Hypoxemia) 11/2017
1	Rectal Neoplasms (Rectal Cancer) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Breast Neoplasms (Breast Cancer) 03/2016
1	Neoplasm Metastasis (Metastasis) 01/2015

Drug/Important Bio-Agent (IBA)

4	Small Interfering RNA (siRNA)IBA 11/2023 - 07/2020
4	ErbB Receptors (EGF Receptor)IBA 09/2023 - 09/2019
4	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2023 - 01/2019
4	Therapeutic UsesIBA 07/2021 - 01/2017
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2020 - 01/2018
3	Histone Deacetylases (Histone Deacetylase)IBA 11/2022 - 01/2015
3	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 01/2020
2	SirtuinsIBA 11/2022 - 11/2017
2	HydrogelsIBA 07/2021 - 05/2021
2	ProdrugsIBA 01/2021 - 01/2019
2	AntibodiesIBA 10/2020 - 12/2019
2	ChromatinIBA 01/2020 - 01/2018
2	NAD (NADH)IBA 11/2017 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 07/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023
1	1- (4- chlorophenylhydrazono)- 1- (4- chlorophenylamino)- 3,3- dimethyl- 2- butanoneIBA 10/2023
1	Oncogene Proteins (Oncogene Protein)IBA 10/2023
1	osimertinibIBA 09/2023
1	phytochlorinIBA 05/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2023
1	LigandsIBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2022
1	LipidsIBA 11/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	2-cyanobenzothiazoleIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 07/2021
1	Polycomb Repressive Complex 2IBA 01/2021
1	4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2021
1	PlatinumIBA 01/2021
1	B7-H1 AntigenIBA 10/2020
1	Photosensitizing Agents (Photosensitizers)IBA 07/2020
1	Formaldehyde (Formol)FDA Link 06/2020
1	ParaffinIBA 06/2020
1	Anaplastic Lymphoma KinaseIBA 06/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 09/2019
1	Trans-Activators (Trans-Acting Factor)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Histones (Histone)IBA 01/2018
1	Lysine (L-Lysine)FDA Link 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	Glutathione (Reduced Glutathione)IBA 03/2016
1	Nucleosomes (Nucleosome)IBA 01/2015
1	Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA 01/2015

Therapy/Procedure

10	Therapeutics 11/2023 - 01/2017
4	Drug Therapy (Chemotherapy) 11/2023 - 01/2018
3	Immunotherapy 07/2021 - 12/2019
3	Lasers (Laser) 05/2021 - 01/2018
3	Photochemotherapy (Photodynamic Therapy) 01/2020 - 01/2018
2	Injections 07/2021 - 05/2021
1	Intravenous Injections 09/2023
1	Photothermal Therapy 05/2021
1	Radiotherapy 01/2017